FEPI:NSD-REX FANG & Innovation Equity Premium Income ETF (USD)

ETF | Others |

Last Closing

USD 55.76

Change

+0.30 (+0.54)%

Market Cap

USD 0.27B

Volume

0.18M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+1.46 (+0.73%)

USD 31.98B
ACWI iShares MSCI ACWI ETF

+1.32 (+1.11%)

USD 19.10B
IBIT iShares Bitcoin Trust

+0.87 (+2.42%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.06 (+0.28%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.16 (+0.29%)

USD 16.09B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTF iShares iBonds Dec 2025 Term T..

-0.01 (-0.02%)

USD 2.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.06B
PABU iShares Paris-Aligned Climate ..

+0.19 (+0.30%)

USD 2.05B
NVDL GraniteShares 1.5x Long NVDA D..

+0.42 (+0.70%)

USD 2.05B

ETFs Containing FEPI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.74% 44% F 57% F
Dividend Return 10.52% 99% N/A 99% N/A
Total Return 11.26% 75% C 76% C+
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.27B 81% B- 53% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike